Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Richard Doubleday. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Richard Doubleday har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:DXCM / DexCom, Inc. | EVP Chief Commercial Officer | 6 654 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Richard Doubleday. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Richard Doubleday som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-03-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −94 | 6 654 | −1,39 | 362,45 | −34 070 | 2 411 742 |
2021-03-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −268 | 6 748 | −3,82 | 361,37 | −96 847 | 2 438 513 |
2021-03-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −655 | 7 016 | −8,54 | 360,33 | −236 018 | 2 528 091 |
2021-03-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −74 | 7 671 | −0,96 | 358,13 | −26 502 | 2 747 215 |
2021-03-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −18 | 7 745 | −0,23 | 352,88 | −6 352 | 2 733 056 |
2021-02-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 110 | 7 763 | −12,51 | 404,00 | −448 440 | 3 136 252 |
2021-01-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −11 | 8 873 | −0,12 | 371,98 | −4 092 | 3 300 615 |
2021-01-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −310 | 8 884 | −3,37 | 370,24 | −114 776 | 3 289 246 |
2021-01-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −254 | 9 194 | −2,69 | 369,31 | −93 804 | 3 395 404 |
2021-01-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −169 | 9 448 | −1,76 | 368,20 | −62 226 | 3 478 773 |
2021-01-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −366 | 9 617 | −3,67 | 367,51 | −134 510 | 3 534 374 |
2021-01-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −10 970 | 21 524 | −33,76 | 366,07 | −4 015 788 | 7 879 291 | |
2021-01-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −28 | 32 494 | −0,09 | 365,16 | −10 224 | 11 865 376 | |
2021-01-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −27 | 32 522 | −0,08 | 362,96 | −9 800 | 11 804 292 | |
2021-01-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | −950 | 32 549 | −2,84 | ||||
2020-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −80 | 9 983 | −0,79 | 364,15 | −29 132 | 3 635 284 |
2020-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −60 | 10 063 | −0,59 | 362,83 | −21 770 | 3 651 191 |
2020-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −180 | 10 123 | −1,75 | 361,46 | −65 063 | 3 659 071 |
2020-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −123 | 10 303 | −1,18 | 360,62 | −44 356 | 3 715 437 |
2020-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −282 | 10 426 | −2,63 | 359,29 | −101 319 | 3 745 947 |
2020-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −265 | 10 708 | −2,42 | 358,48 | −94 998 | 3 838 640 |
2020-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −120 | 10 973 | −1,08 | 357,31 | −42 878 | 3 920 803 |
2020-11-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 110 | 11 093 | −9,10 | 318,99 | −354 079 | 3 538 556 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −83 | 12 203 | −0,68 | 408,00 | −33 864 | 4 978 824 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −68 | 12 286 | −0,55 | 406,93 | −27 671 | 4 999 542 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −263 | 12 354 | −2,08 | 406,45 | −106 896 | 5 021 257 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −213 | 12 617 | −1,66 | 405,07 | −86 280 | 5 110 762 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −6 | 12 830 | −0,05 | 403,49 | −2 421 | 5 176 777 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −74 | 12 836 | −0,57 | 402,57 | −29 790 | 5 167 340 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −156 | 12 910 | −1,19 | 399,63 | −62 342 | 5 159 223 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −247 | 13 066 | −1,86 | 397,49 | −98 180 | 5 193 615 |
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 13 313 | 13 313 | |||||
2020-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −13 313 | 33 499 | −28,44 | ||||
2020-09-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 430 | 0 | −100,00 | 381,00 | −544 830 | |
2020-09-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −100 | 1 430 | −6,54 | 380,31 | −38 031 | 543 837 |
2020-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 402 | 46 812 | −2,91 | 398,30 | −558 419 | 18 645 313 | |
2020-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −3 297 | 48 214 | −6,40 | 398,30 | −1 313 202 | 19 203 733 | |
2020-08-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 530 | 1 530 | −50,00 | 427,22 | −653 642 | 653 642 |
2020-07-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −571 | 3 060 | −15,73 | 429,60 | −245 303 | 1 314 582 |
2020-07-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −107 | 3 631 | −2,86 | 428,52 | −45 851 | 1 555 943 |
2020-07-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −476 | 3 738 | −11,30 | 427,36 | −203 423 | 1 597 472 |
2020-07-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −94 | 4 214 | −2,18 | 425,99 | −40 043 | 1 795 122 |
2020-07-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −83 | 4 308 | −1,89 | 424,63 | −35 244 | 1 829 306 |
2020-07-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −200 | 4 391 | −4,36 | 421,62 | −84 323 | 1 851 311 |
2020-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −227 | 4 591 | −4,71 | 411,54 | −93 419 | 1 889 369 |
2020-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −595 | 4 818 | −10,99 | 410,26 | −244 107 | 1 976 648 |
2020-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −354 | 5 413 | −6,14 | 408,90 | −144 750 | 2 213 370 |
2020-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −355 | 5 767 | −5,80 | 407,13 | −144 531 | 2 347 922 |
2020-05-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 531 | 6 122 | −20,01 | 396,74 | −607 409 | 2 428 842 |
2020-04-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 530 | 7 653 | −16,66 | 318,57 | −487 412 | 2 438 016 |
2020-03-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 300 | 9 183 | −12,40 | 209,55 | −272 415 | 1 924 298 |
2020-03-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −231 | 10 483 | −2,16 | 207,71 | −47 981 | 2 177 409 |
2020-03-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | −523 | 51 482 | −1,01 | ||||
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −7 974 | 52 005 | −13,29 | 265,43 | −2 116 507 | 13 803 479 | |
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −189 | 59 979 | −0,31 | 250,02 | −47 254 | 14 995 950 | |
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −140 | 60 168 | −0,23 | 245,71 | −34 400 | 14 783 945 | |
2020-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 11 748 | 60 308 | 24,19 | 0,00 | 12 | 60 | |
2020-02-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −88 | 10 714 | −0,81 | 283,09 | −24 912 | 3 033 036 |
2020-02-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −125 | 10 802 | −1,14 | 278,61 | −34 826 | 3 009 545 |
2020-02-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −852 | 10 927 | −7,23 | 278,03 | −236 882 | 3 038 045 |
2020-02-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −467 | 11 779 | −3,81 | 275,99 | −128 887 | 3 250 866 |
2020-01-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −500 | 12 246 | −3,92 | 236,09 | −118 044 | 2 891 134 |
2020-01-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −300 | 12 746 | −2,30 | 234,26 | −70 278 | 2 985 878 |
2020-01-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −732 | 13 046 | −5,31 | 233,17 | −170 681 | 3 041 954 |
2019-12-23 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −202 | 13 778 | −1,44 | 213,61 | −43 150 | 2 943 143 |
2019-12-23 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 331 | 13 980 | −8,69 | 212,93 | −283 408 | 2 976 742 |
2019-11-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −233 | 15 311 | −1,50 | 218,52 | −50 915 | 3 345 775 |
2019-11-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 300 | 15 544 | −7,72 | 217,39 | −282 604 | 3 379 074 |
2019-10-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −100 | 16 844 | −0,59 | 153,34 | −15 334 | 2 582 859 |
2019-10-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −800 | 16 944 | −4,51 | 152,71 | −122 168 | 2 587 515 |
2019-10-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −633 | 17 744 | −3,44 | 151,70 | −96 029 | 2 691 832 |
2019-10-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 18 377 | 18 377 | |||||
2019-10-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −18 377 | 48 444 | −27,50 | ||||
2019-09-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −519 | 0 | −100,00 | 155,57 | −80 743 | |
2019-09-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 497 | 519 | −74,26 | 154,80 | −231 739 | 80 342 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 525 | 66 821 | −7,64 | 150,11 | −829 364 | 10 030 574 | |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −318 | 72 346 | −0,44 | 145,38 | −46 231 | 10 517 611 | |
2019-08-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −896 | 2 016 | −30,77 | 175,88 | −157 586 | 354 568 |
2019-08-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 120 | 2 912 | −27,78 | 174,56 | −195 502 | 508 305 |
2019-07-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −836 | 4 032 | −17,17 | 154,99 | −129 570 | 624 911 |
2019-07-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −200 | 4 868 | −3,95 | 153,78 | −30 755 | 748 577 |
2019-07-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −980 | 5 068 | −16,20 | 152,29 | −149 246 | 771 813 |
2019-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −592 | 6 048 | −8,92 | 151,09 | −89 448 | 913 817 |
2019-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 424 | 6 640 | −17,66 | 149,00 | −212 178 | 989 370 |
2019-05-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 100 | 8 064 | −12,00 | 117,65 | −129 410 | 948 693 |
2019-05-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −916 | 9 164 | −9,09 | 116,86 | −107 042 | 1 070 886 |
2019-04-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 200 | 10 080 | −10,64 | 117,27 | −140 724 | 1 182 082 |
2019-04-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −816 | 11 280 | −6,75 | 116,56 | −95 114 | 1 314 811 |
2019-03-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 400 | 12 096 | −10,37 | 127,77 | −178 884 | 1 545 562 |
2019-03-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −616 | 13 496 | −4,37 | 126,47 | −77 905 | 1 706 827 |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 191 | 72 570 | −2,93 | 142,79 | −312 858 | 10 362 430 | |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −6 399 | 74 761 | −7,88 | 142,79 | −913 727 | 10 675 288 | |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 221 | 81 160 | −2,66 | 142,79 | −317 141 | 11 589 015 | |
2019-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 16 365 | 83 381 | 24,42 | 0,00 | 16 | 83 | |
2018-12-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −310 | 14 112 | −2,15 | 110,61 | −34 288 | 1 560 866 |
2018-12-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −700 | 14 422 | −4,63 | 109,57 | −76 700 | 1 580 239 |
2018-12-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −500 | 15 122 | −3,20 | 108,23 | −54 113 | 1 636 597 |
2018-11-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 236 | 15 622 | −7,33 | 122,00 | −150 795 | 1 905 921 |
2018-11-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −500 | 16 858 | −2,88 | 119,74 | −59 869 | 2 018 543 |
2018-10-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −100 | 17 358 | −0,57 | 129,78 | −12 978 | 2 252 721 |
2018-10-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 636 | 17 458 | −8,57 | 128,66 | −210 488 | 2 246 145 |
2018-09-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −220 | 19 094 | −1,14 | 142,49 | −31 348 | 2 720 756 |
2018-09-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −556 | 19 314 | −2,80 | 141,76 | −78 817 | 2 737 899 |
2018-09-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −820 | 19 870 | −3,96 | 140,84 | −115 491 | 2 798 544 |
2018-09-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −80 | 20 690 | −0,39 | 139,72 | −11 178 | 2 890 859 |
2018-09-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −60 | 20 770 | −0,29 | 138,25 | −8 295 | 2 871 384 |
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −3 180 | 66 804 | −4,54 | 143,76 | −457 142 | 9 603 422 | |
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 303 | 69 984 | −3,19 | 143,76 | −331 068 | 10 060 564 | |
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 20 830 | 20 830 | |||||
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −20 830 | 72 287 | −22,37 | ||||
2018-08-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 143,09 | −14 309 | |
2018-08-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −550 | 100 | −84,62 | 140,52 | −77 287 | 14 052 |
2018-08-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 934 | 650 | −74,85 | 139,73 | −270 236 | 90 824 |
2018-07-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −450 | 1 067 | −29,66 | 103,30 | −46 487 | 110 226 |
2018-07-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 131 | 1 517 | −58,42 | 102,31 | −218 026 | 155 207 |
2018-06-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 581 | 3 648 | −41,44 | 98,58 | −254 431 | 359 614 |
2018-05-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 581 | 6 229 | −29,30 | 86,00 | −221 963 | 535 686 |
2018-04-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 581 | 8 810 | −22,66 | 73,09 | −188 649 | 643 936 |
2018-03-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 581 | 11 391 | −18,47 | 68,44 | −176 643 | 779 595 |
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 252 | 94 429 | −4,31 | 60,73 | −258 227 | 5 734 730 | |
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 835 | 98 681 | −2,79 | 60,73 | −172 171 | 5 992 956 | |
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 221 | 101 516 | −2,14 | 60,73 | −134 883 | 6 165 128 | |
2018-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 38 502 | 103 737 | 59,02 | 0,00 | 39 | 104 | |
2018-02-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 638 | 13 972 | −10,49 | 56,32 | −92 252 | 786 904 |
2018-01-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 635 | 15 610 | −9,48 | 54,67 | −89 384 | 853 383 |
2017-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 635 | 17 245 | −8,66 | 56,39 | −92 204 | 972 509 | |
2017-11-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 635 | 18 880 | −7,97 | 55,53 | −90 788 | 1 048 363 | |
2017-10-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 635 | 20 515 | −7,38 | 44,82 | −73 274 | 919 392 |
2017-09-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 635 | 22 150 | −6,87 | 69,77 | −114 080 | 1 545 485 |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 184 | 65 049 | −6,04 | 71,81 | −300 467 | 4 671 390 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 347 | 69 233 | −4,61 | 71,81 | −240 359 | 4 971 857 | |
2017-08-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 635 | 23 785 | −6,43 | 75,26 | −123 053 | 1 790 100 |
2017-06-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 187 | 25 420 | −11,14 | 78,22 | −249 273 | 1 988 238 |
2017-05-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 28 607 | −10,01 | 68,29 | −217 290 | 1 953 495 |
2017-04-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 6 369 | −33,32 | 75,78 | −241 131 | 482 641 |
2017-03-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 9 551 | −24,99 | 76,38 | −243 029 | 729 468 |
2017-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 208 | 97 815 | −3,18 | 77,55 | −248 782 | 7 585 612 | |
2017-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 527 | 101 023 | −3,37 | 77,55 | −273 521 | 7 834 394 | |
2017-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 694 | 104 550 | −6,02 | 77,55 | −519 124 | 8 107 915 | |
2017-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 27 510 | 111 244 | 32,85 | 0,00 | 28 | 111 | |
2017-02-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 12 733 | −19,99 | 78,42 | −249 530 | 998 510 |
2017-01-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 15 915 | −16,66 | 79,50 | −252 978 | 1 265 285 |
2016-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 19 097 | −14,28 | 62,17 | −197 831 | 1 187 299 |
2016-11-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 22 279 | −12,50 | 70,19 | −223 350 | 1 563 803 |
2016-10-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 25 461 | −11,11 | 81,12 | −258 110 | 2 065 282 |
2016-09-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 28 643 | −10,00 | 93,97 | −299 000 | 2 691 468 |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 223 | 83 582 | −4,81 | 93,72 | −395 791 | 7 833 531 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 445 | 87 805 | −4,82 | 93,72 | −416 597 | 8 229 322 | |
2016-08-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 31 825 | −9,09 | 90,89 | −289 224 | 2 892 692 |
2016-07-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 182 | 35 007 | −8,33 | 87,31 | −277 822 | 3 056 475 |
2016-06-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 650 | 92 250 | −2,79 | 63,51 | −168 304 | 5 858 890 | |
2016-05-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 674 | 38 189 | −4,20 | 63,59 | −106 446 | 2 428 362 |
2016-04-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 666 | 39 863 | −4,01 | 69,15 | −115 206 | 2 756 574 |
2016-03-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 666 | 13 407 | −11,05 | 61,76 | −102 893 | 828 026 |
2016-03-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 430 | 123 022 | −3,48 | 63,96 | −283 348 | 7 868 622 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 076 | 127 452 | −5,96 | 63,18 | −510 242 | 8 052 417 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 328 | 135 528 | −2,40 | 63,18 | −210 263 | 8 562 659 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 38 000 | 138 856 | 37,68 | 0,00 | 38 | 139 | |
2016-02-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 666 | 15 073 | −9,95 | 64,36 | −107 221 | 970 071 |
2016-01-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 666 | 16 739 | −9,05 | 73,34 | −122 183 | 1 227 623 |
2015-12-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 666 | 18 405 | −8,30 | 82,22 | −136 979 | 1 513 259 |
2015-11-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 666 | 20 071 | −7,66 | 85,85 | −143 024 | 1 723 073 |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −988 | 0 | −100,00 | 83,68 | −82 673 | ||
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 0 | −100,00 | 83,68 | −167 354 | ||
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −12 | 0 | −100,00 | 83,68 | −1 004 | ||
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 000 | 100 483 | −1,95 | 83,68 | −167 354 | 8 408 096 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 000 | 102 483 | 1,99 | 6,03 | 12 060 | 617 972 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −12 | 100 483 | −0,01 | 83,68 | −1 004 | 8 408 096 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 12 | 100 495 | 0,01 | 9,80 | 118 | 984 851 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −988 | 100 483 | −0,97 | 83,68 | −82 673 | 8 408 096 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 988 | 101 471 | 0,98 | 9,80 | 9 682 | 994 416 | |
2015-10-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 666 | 21 737 | −7,12 | 79,27 | −132 059 | 1 723 031 |
2015-09-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 217 | 23 403 | −15,27 | 97,00 | −409 061 | 2 270 159 |
2015-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 416 | 100 483 | −4,21 | 95,93 | −423 638 | 9 639 595 | |
2015-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 404 | 104 899 | −4,03 | 90,90 | −400 317 | 9 535 162 | |
2015-08-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 666 | 27 620 | −5,69 | 80,96 | −134 874 | 2 236 027 |
2015-07-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −9 641 | 29 286 | −24,77 | 85,37 | −823 011 | 2 500 020 |
2015-06-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 623 | 147 945 | −1,74 | 71,61 | −187 833 | 10 594 341 | |
2015-05-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −3 258 | 150 568 | −2,12 | 70,73 | −230 432 | 10 649 374 | |
2015-03-25 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 2 000 | −66,67 | 61,25 | −244 992 | 122 496 | |
2015-03-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 153 826 | −2,53 | 61,25 | −244 992 | 9 421 535 |
2015-03-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 157 826 | 2,60 | 6,03 | 24 120 | 951 691 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −17 500 | 988 | −94,66 | 59,28 | −1 037 320 | 58 564 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −2 500 | 12 | −99,52 | 58,94 | −147 358 | 707 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 500 | 153 826 | −1,60 | 58,94 | −147 358 | 9 066 966 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 500 | 156 326 | 1,63 | 9,80 | 24 500 | 1 531 995 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −17 500 | 153 826 | −10,21 | 59,28 | −1 037 320 | 9 118 098 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 17 500 | 171 326 | 11,38 | 9,80 | 171 500 | 1 678 995 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 448 | 153 826 | −2,81 | 58,58 | −260 549 | 9 010 604 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 121 | 158 274 | −4,88 | 58,74 | −477 029 | 9 297 046 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −1 629 | 166 395 | −0,97 | 58,74 | −95 688 | 9 774 092 | |
2015-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 47 500 | 168 024 | 39,41 | 0,00 | 48 | 168 | |
2015-02-25 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 6 000 | −40,00 | 63,58 | −254 334 | 381 501 | |
2015-02-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 120 524 | −3,21 | 63,58 | −254 334 | 7 663 338 |
2015-02-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 124 524 | 3,32 | 6,03 | 24 120 | 750 880 | |
2015-01-27 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 10 000 | −28,57 | 58,22 | −232 864 | 582 161 | |
2015-01-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 119 950 | −3,23 | 58,22 | −232 864 | 6 983 021 |
2015-01-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 123 950 | 3,33 | 6,03 | 24 120 | 747 418 | |
2014-12-24 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 14 000 | −22,22 | 54,69 | −218 778 | 765 722 | |
2014-12-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 119 950 | −3,23 | 54,69 | −218 778 | 6 560 593 |
2014-12-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 123 950 | 3,33 | 6,03 | 24 120 | 747 418 | |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 18 000 | −18,18 | 50,36 | −201 446 | 906 509 | |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 119 950 | −3,23 | 50,36 | −201 446 | 6 040 874 |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 123 950 | 3,33 | 6,03 | 24 120 | 747 418 | |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 18 000 | −18,18 | 50,36 | −201 446 | 906 509 | |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 119 950 | −3,23 | 50,36 | −201 446 | 6 040 874 |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 123 950 | 3,33 | 6,03 | 24 120 | 747 418 | |
2014-10-24 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 22 000 | −15,38 | 43,58 | −174 310 | 958 703 | |
2014-10-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 119 950 | −3,23 | 43,58 | −174 310 | 5 227 109 |
2014-10-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 123 950 | 3,33 | 6,03 | 24 120 | 747 418 | |
2014-09-24 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 26 000 | −13,33 | 40,32 | −161 262 | 1 048 200 | |
2014-09-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 119 950 | −3,23 | 40,32 | −161 262 | 4 835 832 |
2014-09-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 123 950 | 3,33 | 6,03 | 24 120 | 747 418 | |
2014-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 404 | 119 950 | −3,54 | 43,36 | −190 968 | 5 201 320 | |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 228 | 124 354 | −1,76 | 43,23 | −96 321 | 5 376 085 | |
2014-08-27 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 000 | 30 000 | −11,76 | 44,35 | −177 406 | 1 330 545 | |
2014-08-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 126 582 | −3,06 | 44,35 | −177 406 | 5 614 102 |
2014-08-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 130 582 | 3,16 | 6,03 | 24 120 | 787 409 | |
2014-08-20 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 18 488 | −51,96 | 45,01 | −900 278 | 832 217 | |
2014-08-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −20 000 | 126 582 | −13,64 | 45,01 | −900 278 | 5 697 949 | |
2014-08-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 20 000 | 146 582 | 15,80 | 9,80 | 196 000 | 1 436 504 | |
2014-07-24 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 751 | 34 000 | −9,94 | 38,16 | −143 151 | 1 297 559 | |
2014-07-24 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −249 | 0 | −100,00 | 38,16 | −9 503 | ||
2014-07-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 751 | 126 136 | −2,89 | 38,16 | −143 151 | 4 813 791 |
2014-07-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 3 751 | 129 887 | 2,97 | 6,03 | 22 619 | 783 219 | |
2014-07-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −249 | 126 136 | −0,20 | 38,16 | −9 503 | 4 813 791 |
2014-07-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 249 | 126 385 | 0,20 | 6,03 | 1 501 | 762 102 | |
2014-06-25 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 000 | 249 | −94,14 | 40,98 | −163 925 | 10 204 | |
2014-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 126 136 | −3,07 | 40,98 | −163 925 | 5 169 217 |
2014-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 130 136 | 3,17 | 6,03 | 24 120 | 784 720 | |
2014-06-06 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 000 | 4 249 | −48,49 | 35,59 | −142 356 | 151 217 | |
2014-06-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 126 136 | −3,07 | 35,59 | −142 356 | 4 489 041 |
2014-06-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 130 136 | 3,17 | 6,03 | 24 120 | 784 720 | |
2014-06-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 637 | 126 136 | −2,05 | 33,64 | −88 709 | 4 243 215 | |
2014-05-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −18 750 | 128 773 | −12,71 | 32,89 | −616 609 | 4 234 803 | |
2014-04-25 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 000 | 8 249 | −32,66 | 35,92 | −143 689 | 296 322 | |
2014-04-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 000 | 147 523 | −2,64 | 35,92 | −143 689 | 5 299 351 |
2014-04-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 000 | 151 523 | 2,71 | 6,03 | 24 120 | 913 684 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −50 000 | 12 249 | −80,32 | 46,42 | −2 321 245 | 568 659 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −5 923 | 146 520 | −3,89 | 45,22 | −267 848 | 6 625 869 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −50 000 | 152 443 | −24,70 | 46,42 | −2 321 245 | 7 077 151 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 50 000 | 202 443 | 32,80 | 6,03 | 301 500 | 1 220 731 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 694 | 152 443 | −1,74 | 46,10 | −124 197 | 7 027 836 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 50 000 | 155 137 | 47,56 | 0,00 | 50 | 155 | |
2013-09-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 663 | 105 137 | −2,47 | 26,89 | −71 606 | 2 827 071 | |
2013-06-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 15 000 | 106 973 | 16,31 | 0,00 | 15 | 107 | |
2013-05-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −580 | 91 973 | −0,63 | 19,56 | −11 344 | 1 798 882 | |
2013-05-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −692 | 92 553 | −0,74 | 19,55 | −13 531 | 1 809 744 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 067 | 93 245 | −4,18 | 15,69 | −63 811 | 1 463 014 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 100 | 97 312 | −4,98 | 15,63 | −79 699 | 1 520 724 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 50 000 | 102 412 | 95,40 | 0,00 | 50 | 102 | |
2012-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −1 302 | 51 430 | −2,47 | 13,68 | −17 807 | 703 393 | |
2012-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 777 | 52 040 | −5,07 | 10,26 | −28 487 | 533 842 | |
2012-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 25 625 | 54 817 | 87,78 | 0,00 | 26 | 55 |